首页> 外文期刊>Acta biomaterialia >Poly(N-isopropylacrylamide)-based dual-crosslinking biohybrid injectable hydrogels for vascularization
【24h】

Poly(N-isopropylacrylamide)-based dual-crosslinking biohybrid injectable hydrogels for vascularization

机译:聚(N-异丙基丙烯酰胺)基于双交联的生物红外可注射水凝胶,用于血管化

获取原文
获取原文并翻译 | 示例
           

摘要

Injectable hydrogels provide a powerful and non-invasive approach for numerous applications in cell transplantation, growth factor delivery, tissue regeneration and so forth. The properties of injectable hydrogels should be well-tuned for specific applications, where their overall design should ensure biocompatibility, non-toxicity, robust mechanical properties, and most importantly the ability to promote vascularization and integration with the host tissue/organ. Among these criteria, vascularization remains a key design element in the development of functional therapeutic hydrogels for successful translation into clinical settings. To that end, there is still a critical need for the development of the next generation of injectable hydrogels with precisely tuned biophysical and biochemical properties which could simultaneously promote tissue vascularization. In this work, we developed a temperature responsive, dual-crosslinking, biohybrid hydrogels, modified with a vasculogenic peptide for applications in regenerative medicine, specifically tissue vascularization. The synthesized hydrogels consisted of poly(N-isopropylacrylamide)-based copolymer, functionalized gelation and angiogenic VEGF-mimetic QK peptide with enhanced shear-thinning and injectability properties. QK peptide is a VEGF-mimetic vasculogenic peptide which binds to VEGF receptors and activates intercellular pathway for vascularization. Apart from the presence of QK peptide, the mechanical properties of the hydrogels were precisely tuned by altering the polymer concentration, enabling successful assembly and endothelial cell network formation. Extended in vitro studies demonstrated successful encapsulation and homogeneous distribution of endothelial cells within the three-dimensional (3D) environment of the hydrogel matrix with significantly enhanced vascularization in presence of the QK peptide as early as 3 days of culture. A small, preliminary in vivo study in mice showed a trend of increased blood vessel formation in hydrogels that incorporated the QK peptide. Overall, our study presents the design and characterization of injectable, dual-crosslinking and vasculogenic hydrogels with controlled properties which could be utilized for numerous applications in regenerative medicine, minimally invasive cell and drug delivery as well as fundamental studies on tissue vascularization and angiogenesis.
机译:可注射水凝胶为细胞移植,生长因子输送,组织再生等众多应用提供了强大而非侵入性的方法。应良好地调整注射水凝胶的性质,用于特定应用,其整体设计应确保生物相容性,无毒,鲁棒性能,以及最重要的是促进血管化和与宿主组织/器官集成的能力。在这些标准中,血管化仍然是在临床环境中成功翻译的功能性治疗水凝胶的开发中的关键设计元素。为此,仍然仍然需要在具有精确调谐的生物物理和生化特性的下一代可注射水凝胶的临时需求,这可以同时促进组织血管化。在这项工作中,我们开发了一种温度响应,双交联,生物冬小水凝胶,用血管原肽改性,用于在再生医学中的应用,特别是组织血管化。合成的水凝胶由聚(N-异丙基丙烯酰胺)基于聚合物,官能化凝胶化和血管生成VEGF - 模拟Qk肽,具有增强的剪切稀释性和可注射性能。 QK肽是VEGF模拟血管原性肽,其与VEGF受体结合并激活细胞间途径以进行血管化。除了QK肽的存在之外,通过改变聚合物浓度来精确调整水凝胶的机械性能,从而实现成功的组装和内皮细胞网络形成。延长的体外研究表明了水凝胶基质的三维(3D)环境内的内皮细胞内皮细胞的成功包封和均匀分布,早在培养的3天内,QK肽存在明显增强。小鼠体内研究中的一个小初步,表明,掺入QK肽的水凝胶中血管形成增加的趋势。总体而言,我们的研究介绍了可注射,双交联和血管原性水凝胶的设计和表征,可控制性能,可用于再生医学的许多应用,微创细胞和药物递送以及对组织血管化和血管生成的基本研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号